It has been shown in animal experiments that angiotensin II and aldosterone have mitogenic effects on the cardiovascular system, whereas atrial natriuretic peptide has antimitogenic properties. The aim of the present study was to relate plasma renin activity, angiotensin II, aldosterone and atrial natriuretic peptide to left ventricular structure and function, assessed by use of imaging echocardiography and transmitral Doppler velocimetry in 73 patients with essential hypertension, World Health Organization stages I-II, aged 43 ؎ 10 (s.d.) years. Left ventricular mass, wall thickness and internal diameter were not independently related to the biochemical variables, except for a weak and positive association of wall thickness with plasma aldosterone (P ‫؍‬ 0.06). However, left ventricular early inflow peak velocity and deceleration were independently and inversely related to age
Introduction
There is evidence from animal experiments that angiotensin II and aldosterone exert mitogenic effects on the cardiovascular system, whereas atrial natriuretic peptide has antimitogenic properties. [1] [2] [3] [4] [5] The development of cardiac fibrosis on long-term in vivo administration of aldosterone in rats has generated considerable interest, particularly because of its seemingly independence of haemodynamic factors; [6] [7] [8] [9] however, in vitro studies are not in agreement on the direct effect of aldosterone on collagen synthesis by cultured cardiac fibroblasts. 10, 11 Atrial natriuretic peptide on the other hand has been shown to inhibit the proliferation of cultured rat fibroblasts, 12 but it is not known whether long-term infusion of atrial natriuretic peptide would counteract or reverse the fibrotic process. Such issues are of paramount importance for human hypertensive heart disease, but are difficult to resolve in man, because long-term administration of components of the renin-angiotensin-aldosterone-system and of atrial natriuretic peptide cannot be performed on ethical grounds. Therefore researchers have looked for associations between cardiac structure and function, and plasma renin activity, [13] [14] [15] [16] [17] [18] [19] [20] [21] angiotensin II, 15, 17, 20, 22 aldosterone 15, [17] [18] [19] [20] 22, 23 and atrial natriuretic peptide. 22, [24] [25] [26] [27] Another approach has been to study the cardiac effects of chronic treatment with drugs which interfere with components of the reninangiotensin-system. 28, 29 Growth stimulation of myocytes would lead to an increase in left ventricular mass, whereas myocardial fibrosis would mainly result in functional abnormalities, particularly diastolic dysfunction. 3 Imaging echocardiography is an appropriate non-invasive technique to estimate left ventricular mass, whereas mitral inflow Doppler velocimetry allows assessment of diastolic function. 30 Moreover, echocardiographic indices of diastolic function correlate with myocardial fibrosis in hypertensive man. 31 Few studies have addressed the relationships of plasma atrial natriuretic peptide with left ventricular characteristics, 22, [24] [25] [26] [27] whereas the data on the renin-angiotensin-system, both from the correlation approach and from intervention studies are conflicting. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] 28, 29 In addition, most reports emphasized cardiac structure, whereas relationships of humoral variables with diastolic function have only been studied for atrial natriuretic peptide and not for the components of the reninangiotensin-system. The purpose of the present study was therefore to assess relationships of echocardiographic left ventricular structural and functional characteristics with plasma renin activity, angiotensin II, aldosterone and atrial natriuretic peptide in patients with essential hypertension, studied in well-standardized conditions.
Materials and methods

Protocol
Previously treated or untreated patients, referred for the evaluation of hypertension, were eligible for the study when no underlying disease could be detected, when organ damage was limited to World Health Organization stages I or II 32 and when their echocardiogram was judged to be of good quality by two investigators. Patients willing to participate were invited for two study visits within the next 6 weeks, with 2 to 3 weeks between visits; visits were scheduled in the morning, after the patients had a light breakfast at home. Anti-hypertensive treatment was interrupted in patients with mild-to-moderate hypertension. Patients with severe blood pressure elevation were only accepted when they were untreated and the two study visits were scheduled in a shorter period of time. No special diet instructions were given and sodium intake was assessed from 24-h urinary sodium excretion. The study was approved by the Ethics Committee of the Faculty of Medicine and participants gave informed consent.
Clinic blood pressure
After arrival in the laboratory the patients were left alone in a quiet room, where they rested in the supine position. Twenty minutes later, blood pressure was measured five times by sphygmomanometry and auscultation (Korotkoff phases I and V) by one of two trained observers; pulse rate was assessed at the end of the blood pressure measurement by palpation of the radial artery during 30 s. The five blood pressures of each visit were averaged and mean blood pressure was calculated as: diastolic pressure + (systolic pressure − diastolic pressure)/3.
Imaging echocardiography
Echocardiography was performed by one of two operators under supervision of the same third investigator, by use of an Ultra-Imager (Honeywell Inc, Denver, CO, USA) or CV 750 device (Vingmed, Horten, Norway), with the subject rotated slightly on the left side. 33 M-mode echocardiograms of the left ventricle were obtained at end-expiration from the long axis view, under control of the two-dimensional image, and were recorded on photographic paper at paper speed 100 mm/s for later analysis. The transducer was angulated to ensure simultaneous visualisation of the left ventricular posterior wall and interventricular septum just below the mitral valve apparatus, ie, at the level of the posterior chordae tendinae. After completion of the study the tracings were digitized and the values of three to five heart beats were averaged. The recommendations of the American Society of Echocardiography were observed; wall and cavity measurements were made using the leading edge method. 34 The following echocardiographic measurements were obtained: (1) left ventricular end-diastolic internal diameter (LVID; mm), measured at the onset of the QRS complex of the simultaneously recorded electrocardiogram, and end-systolic internal diameter at the nadir of septal motion (LVIDs; mm); and (2) end-diastolic posterior wall and interventricular septal thicknesses (PWT; IVST; mm). Several indexes were derived from these measurements: (1) mean end-diastolic wall thickness (MWT; mm) as the average of posterior wall and septal thicknesses; (2) left ventricular mass (LVM; g) as described by Devereux et al; 35 (3) relative wall thickness (RWT) as the ratio of MWT to the internal radius (LVID/2); and (4) the fractional shortening of the LV internal diameter (FS; %) as 100 × (LVID − LVIDs)/LVID.
Pulsed Doppler echocardiography
With the patient rotated on the left side, the transducer was placed at the apex and the apical fourchamber image was visualised. The Doppler sample volume was positioned in the orifice of the mitral valve and the ultrasound beam was placed parallel to the presumed flow of blood. The transducer was angulated to obtain the best Doppler signal, as judged by the sharpness of the outline of the complexes on the visual display and the pitch of the audio sound of the Doppler shift frequencies. Recordings were made at end-expiration. The peak velocity (m/s) and deceleration (m/s 2 ) of the early filling curve and the peak velocity of the atrial contraction curve (m/s) were measured on three to five heart beats, using the middle of the darkest portion of the Doppler flow curve. The ratio of the early to atrial peak velocity was calculated.
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Biochemical measurements
After termination of echocardiography, the patients remained in the supine position for withdrawal of blood from an antecubital vein, for determination of plasma renin activity, 37 angiotensin II, 38 aldosterone, 39 atrial natriuretic peptide 40 and plasma noradrenaline. 41 
Statistical analysis
Database management and statistical analyses were performed using SAS-software (SAS Institute Inc, Cary, North Carolina). Results of two visits were averaged, except in two patients who were seen only once. Group data are reported as mean (s.d.) or as median and range. Positively skewed data were logarithmically transformed, provided that transformation improved the skewness index. Results were analysed using single and stepwise multiple regression analysis. A two-tailed P value of р0.05 was considered significant.
Results
Characteristics of patients
Age of the 73 patients (48 men, 25 women) averaged 43.5 ± 10.1 years, weight 75.3 ± 12.6 kg, height 1.71 ± 0.09 m and body mass index 25.6 ± 3.2 kg/m 2 . Blood pressure was 158 ± 19/102 ± 13 mm Hg and pulse rate 70.5 ± 10.4 beats/min. Age, body mass index and blood pressure were not different between men and women; women were smaller, weighed less than men and their pulse rate was higher (P Ͻ 0.05). Median duration of hypertension was 50 months (range 1.5-300). Forty-one patients had never been treated for hypertension or had not received anti-hypertensive drugs for more than 1 month in the previous year. Treatment had been interrupted for a median of 9 weeks and for at least 3 weeks in all ever treated patients. Urinary sodium excretion averaged 99 ± 51 mmol/24 h. Figure 1 gives the median and the individual data for plasma renin activity, angiotensin II, aldosterone and atrial natriuretic peptide, which were available in 72, 71, 71 and 72 patients, respectively, together with the normal ranges in the authors' laboratory. Plasma noradrenaline ranged from 0.66 to 7.9 mol/L (median: 2.04; n = 70). Plasma angiotensin II, atrial natriuretic peptide and noradrenaline were logarithmically transformed in all further analyses. Table 1 summarizes the results from imaging and Doppler echocardiography; when compared to normal values, patients had concentric left ventricular 
Determinants of biochemical variables
Plasma renin activity and angiotensin II were not significantly related to age, sex, height, weight, blood pressure, 24-h urinary sodium excretion, duration of hypertension or use of previous medication. Plasma aldosterone was positively related to mean blood pressure (r = 0.24; P Ͻ 0.05) and plasma noradrenaline to age (r = 0.23; P = 0.05). Single regression analysis revealed that atrial natriuretic peptide was related to age (r = 0.47; P Ͻ 0.001), female vs male sex (r = 0.32; P Ͻ 0.01), mean blood pressure (r = 0.33; P Ͻ 0.01), weight (r = −0.26; P Ͻ 0.05) and height (r = −0.36; P Ͻ 0.01); multiple regression analysis showed independent contributions of age (partial regression coefficient: +0.0105 log pmol/L/yr; P Ͻ 0.001), female sex (+0.146 log pmol/L; P Ͻ 0.05) and mean blood pressure (+0.0045 log pmol/L/mm Hg; P Ͻ 0.05) to atrial natriuretic peptide.
Determinants of left ventricular structural characteristics
When age, sex, height, weight, mean blood pressure, heart rate, 24-h urinary sodium excretion, duration of hypertension and previous medication were offered for selection in stepwise multiple regression analysis, four significant variables explained 64% of the variance of left ventricula mass (P Ͻ 0.001), that is mean blood pressure (partial regression coefficient: +2.1 g/mm Hg; P Ͻ 0.001), weight (+2.7 g/kg; P Ͻ 0.001), height (−210 g/m; P Ͻ 0.05) and sex (−63 g for women vs men). The same variables explained 54% of the variance of mean wall thickness (P Ͻ 0.001). The left ventricular end-diastolic internal diameter was independently determined by weight (+0.16 mm/kg; P Ͻ 0.001) and heart rate (−0.13 mm/bpm; P Ͻ 0.05) (R 2 = 0.26; P Ͻ 0.001). There were no significant relationships of left ventricular mass, wall thickness and internal diameter with biochemical variables in single regression analysis, except for mean wall thickness and plasma aldosterone (r = 0.27; P Ͻ 0.05) ( Table 2 ). None of the biochemical variables correlated significantly with the left ventricular structural characteristics in multiple regression analysis, when offered for selection together with the demographic, anthropometric and clinical characteristics. The positive relationship between mean wall thickness and aldosterone fell short of significance (P = 0.06) after controlling for mean blood pressure, weight, height and sex.
Determinants of left ventricular inflow characteristics
The single correlation coefficients between left ventricular inflow characteristics and the biochemical measurements are given in Table 2 . Peak velocity and deceleration of the early filling wave were significantly and inversely related to plasma aldos- left ventricular internal diameter; E pv : peak velocity of early filling wave; E dec : deceleration of early filling wave; A pv : peak velocity of atrial filling wave; EA ratio: ratio of early to atrial peak velocity; PRA: plasma renin activity; lANG II: log plasma angiotensin II concentration; ALDO: plasma aldosterone concentration; lANP: log plasma atrial natriuretic peptide concentration; lNAPI: log plasma noradrenaline concentration.
terone (P Ͻ 0.001 (Figure 2 ), but to none of the other biochemical variables. The relationships between the early inflow characteristics and aldosterone remained significant (P Ͻ 0.001) after adjustment for significant covariates, that is age and sex for peak velocity (partial r = −0.39) and age for deceleration (partial r = −0.40). Whereas these inflow characteristics were not significantly related to atrial natriuretic peptide in single regression analysis, these relationships became significant after controlling for age ( Figure 3) ; the partial correlation coefficients amounted to 0.33 (P Ͻ 0.01) and 0.29 (P = 0.01), respectively. Table 3 illustrates the regression equations when all biochemical variables were offered for selection, together with demographic, anthropometric, clinical and left ventricular structural data. The results reveal opposite and independent associations of plasma aldosterone and atrial natriuretic peptide with the early transmitral inflow characteristics; these relationships remained significant when sex was forced into the equations.
Transmitral peak velocity during atrial contraction was positively related to atrial natriuretic peptide, both in single (Table 2 ) and in multiple regression analysis (Table 3 ). The early to late peak flow velocity ratio was influenced by aldosterone and atrial natriuretic peptide in single regression analysis (Table 2 ), but the effect was only independent of significant confounders, ie, age and mean blood pressure, for aldosterone (Table 3) .
Discussion
The main findings of the present study are: (1) that components of the renin-angiotensin-aldosteronesystem and its physiologic antagonist atrial natriuretic peptide are more closely related to echocardio- Other variables offered for selection: plasma renin activity; plasma angiotensin II; plasma noradrenaline; height; weight; left ventricular mass; mean wall thickness; left ventricular internal diameter; 24-h urinary Na excretion; previous medication; duration of hypertension. Abbreviations: see Table 2 .
graphic indices of left ventricular diastolic function than to left ventricular structure in patients with essential hypertension; and (2) that a higher circulating aldosterone is associated with reduced diastolic function, whereas atrial natriuretic peptide shows the opposite relationship.
Although angiotensin II and aldosterone have been shown to have growth stimulating and mitogenic effects on the heart in animal experiments, our cross-sectional findings could suggest that these properties are not of paramount importance for left ventricular hypertrophy in human essential hypertension. It is noteworthy that sex, body size and blood pressure explain 64% of the variance of left ventricular mass and 54% of the variance of mean wall thickness in the present study population. Heredity 33 and various lifestyle factors which have not been assessed, such as physical activity, 43 alcohol consumption 44 and smoking, 45 may have contributed to at least part of the remaining unexplained variance, but we found no relationships of cardiac structure with age, 24-h urinary sodium excretion, plasma noradrenaline and previous anti-hypertensive treatment. Results in the literature on the relationships of left ventricular structure with components of the renin-angiotensin-system have been conflicting. Various populations have been studied, ie, young healthy adults, 20 employed subjects 16 or middle-aged men in a general population, 15 children and adolescents 18 or adults with essential hypertension, 13, 14, 17, 19, 22 and patients with renovascular hypertension. 21 Most authors did not observe a significant relationship of left ventricular mass (index) or wall thickness, or both, with plasma renin activity. [13] [14] [15] 17, 18, 21 Left ventricular mass (index) correlated significantly though weakly (0.30 Ͻ r Ͻ 0.35) with plasma renin activity in one report in young healthy adults 20 and another in hypertensives 19 but independence of possible confounding factors was not assessed. By contrast, stepwise multiple logistic regression revealed that left ventricular hypertrophy was even associated with low renin levels in patients with sustained hypertension. 16 Whereas left ventricular mass (index) was not related to angiotensin II, 15 ,17 significant correlation coefficients have been observed between angiotensin II and wall thickness or left ventricular mass (0.22 Ͻ r Ͻ 0.46), which remained significant after adjustment for confounders such as age, sex, body size, blood pressure and/or urinary sodium excretion. 17, 20, 22 Aldosterone was usually not a determinant of left ventricular structure. 17, 18, 20, 22 Hartford et al 15 reported a weak association between left ventricular mass and aldosterone before (r = 0.26) but not after adjustment for blood pressure. Only Bauwens et al 19 found a relatively strong relationship between left ventricular mass index and aldosterone (r = 0.56) in hypertensives, which remained significant when blood pressure was taken into account. More recently, Rossi et al 23 reported that left ventricular mass and wall thickness were higher in patients with primary aldosteronism compared with those with essential hypertension. Another approach has been to study the regression of left ventricular hypertrophy by drugs with different influences on the renin-angiotensin-system. A recent meta-analysis which was restricted to randomised comparative studies revealed that there is as yet no convincing evidence that anti-hypertensive agents which suppress the renin-angiotensin-system reduce left ventricular mass to a greater extent than other first line drugs to which they were directly compared. 29 An inverse relationship of left ventricular mass and wall thickness with plasma atrial natriuretic peptide might have been expected based on its antigrowth and antimitogenic properties, but this was not observed in the present study or in published reports in normal subjects, 24 hypertensive patients, 22, 24, 27 both combined, 25 or in patients with congestive heart failure due to diastolic dysfunction. 26 Dessì-Fulgheri et al 25 and Schroeder et al 22 even observed a positive association between left ventricular mass index and atrial natriuretic peptide, which remained significant after controlling for significant confounders in the latter study. 22 This finding may be ascribed to atrial natriuretic peptide secretion by the hypertrophied ventricle, which is normally confined to the atrium.
Similar to the results in normal subjects, 42 peak velocity of the early filling wave decreased with age, whereas the atrial peak velocity increased with age. After controlling for age (and sex), peak velocity and deceleration of the early filling wave were inversely related to circulating aldosterone and positively to atrial natriuretic peptide, suggesting that aldosterone is associated with reduced diastolic function and atrial natriuretic peptide with improved diastolic function. It is likely that the echocardiographic measurements can be considered as a surrogate for myocardial fibrosis. Indeed, Sugihara et al 31 demonstrated that the increment of left ventricular volume during the rapid filling phase, assessed by use of Mmode echocardiography, correlated inversely with myocardial interstitial fibrosis, measured on right ventricular endomyocardial biopsies in six normotensive and 18 hypertensive subjects; this relationship was independent of wall thickness. Though these authors did not use Doppler velocimetry, the rate of left ventricular filling volume corresponds with Doppler measurements during early filling. A possible limitation of transmitral Doppler velocimetry is that 'pseudo-normalisation' of the abnormal inflow pattern may occur, but this is likely to be confined to patients with severe hypertension and evolving heart failure. We do not believe that pseudo-normalisation confounded our results because (1) patients with a history of heart failure were excluded, (2) systolic function, assessed by the fractional shortening of the left ventricular internal diameter, was normal, and (3) there was no evidence of reversal of the transmitral inflow pattern in the patients with the highest blood pressure. It is therefore likely that the observed abnormalities during early left ventricular filling, after consideration of other possible determinants such as age, heart rate, left ventricular mass and indices of afterload (blood pressure) and preload (left ventricular internal diameter), 30 are indicative of impaired diastolic function, myocardial stiffness, increased collagen content and fibrosis. 46 To the best of our knowledge, relationships between early transmitral flow characteristics, and, respectively, atrial natriuretic peptide and effector hormones of the renin-angiotensin-system, have not been reported in the literature, but the results are in agreement with the changes of left ventricular diastolic function which have been observed in primary aldosteronism. 23 Peak flow velocity during atrial filling was not significantly related to components of the renin-angiotensin-system but positively to atrial natriuretic peptide. Whereas there are no data on the reninangiotensin-system, Dessì-Fulgheri et al 25 found a similar relationship of atrial natriuretic peptide with atrial peak velocity, whereas Ganau et al 24 described concordant results by use of nuclear angiography, suggesting that atrial natriuretic peptide is associated with diastolic dysfunction. This apparent conflict with the findings during early inflow can most likely be explained by the fact that atrial involvement in hypertensive heart disease not only stimulates the secretion of atrial natriuretic peptide but also affects the atrial filling characteristics.
The present findings could be criticized because they merely represent cross-sectional associations between aldosterone, atrial natriuretic peptide and indices of diastolic function in a particular period in the patients' life, whereas left ventricular remodeling is a long-term process. However, the results are plausible and consistent with results from animal experiments in which long-term infusion of aldosterone led to myocardial fibrosis. [6] [7] [8] [9] In addition, the human heart seems to possess the cellular machinery for direct aldosterone action, because of the coexpression of the mineralo-corticoid receptor and the required protecting enzyme 11 ␤-hydroxysteroid dehydrogenase II. 47 It should be noted, however, that the observation that aldosterone increases the rate of synthesis of collagen by cultured rat cardiac fibroblast 10 has not been confirmed by others.
11
As for atrial natriuretic peptide it has recently been shown that cardiac fibroblasts are capable of expressing atrial natriuretic peptide receptor genes 48 and that atrial natriuretic peptide inhibits cardiac fibroblast proliferation. 12 Finally the cross-sectional approach is more likely to weaken associations, so that significant correlations may represent true and possibly causal relationships; on the other hand, nonsignificant relationships may not allow to refute the existence of true pathophysiological influences of biochemical variables on cardiac structure and function.
